The U.S. Food and Drug Administration (FDA) and drug manufacturer Novo Nordisk are warning consumers about “counterfeit” Ozempic found outside the authorized drug supply chain. The contents of ...

The Food and Drug Administration issued an alert on Monday concerning counterfeit Ozempic that could be in the U.S. drug supply chain ... and should not be used, Novo Nordisk explained.

JD: Novo Nordisk GBS plays a critical role in advancing the global success of our organisation. We strategically represent 17 key functions, including IT, commercial, marketing, supply chain ...

reinforcing its efforts to protect patients and maintain supply chain integrity. As the investigation continues, the FDA and Novo Nordisk are emphasizing the importance of vigilance to ensure the ...

MONDAY, April 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging ... way into the drug supply chain in the United States.